Safety of rhuFabV2, an anti-VEGF antibody fragment, as asingle intravitreal injection in patients with neovascular AMD. - Rosenfeld,P.J.; Schwartz,S.D.; Blumenkranz,M.S. (Vitreous Society, 2001)